Jumpstart Nova

Jumpstart Nova, launched in 2022 with an oversubscribed $55 million fund, is the first venture capital fund exclusively focused on Black-founded and Black-led healthcare companies in the U.S. Based in Nashville and Los Angeles, the fund targets seed and Series A startups in sectors such as health IT, digital health, biotech, diagnostic devices, and tech-enabled healthcare services. Led by founder Marcus Whitney, the fund addresses the long-standing gap in venture capital allocation to Black innovators, with a mission to drive equity in healthcare innovation. Jumpstart Nova’s portfolio includes companies like Alerje, a food allergy management startup, and Cellevolve, a biotech firm focused on cell therapy advancements. The firm is backed by major healthcare institutions including Eli Lilly, HCA Healthcare, and the American Hospital Association, which provide strategic support alongside capital. With a strong focus on fostering both company and leadership development, Jumpstart Nova is more than just a financial investor. The team, which includes partner Kathryne Cooper, works closely with founders, helping them navigate challenges and scale their businesses. Entrepreneurs backed by Jumpstart Nova benefit from their extensive network and industry expertise, ensuring that innovative healthcare solutions from underrepresented groups can thrive.